Page 1 of Clinical Trials for Shionogi Inc. [SPONSOR-COLLABORATORS], 26 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
A Study to Evaluate Daily Pravastatin, Fenofibrate or Pravafen in the Treatment of Combined Hyperlipidemia
Last Updated: July 2, 2009
Condition(s): Combined Hyperlipidemia
2
Completed
Safety Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Condition
Last Updated: November 13, 2009
Condition(s): Sialorrhea; Cerebral Palsy; Neurological Conditions; Mental Retardation
3
Completed
Use of Fenofibrate for Primary Biliary Cirrhosis
Last Updated: December 2, 2011
Condition(s): Primary Biliary Cirrhosis
4
Completed
Efficacy, Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment Premature Ejaculation
Last Updated: July 14, 2010
Condition(s): Premature Ejaculation
5
Recruiting
A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy
Last Updated: October 11, 2011
Condition(s): Opioid Induced Constipation
6
Completed
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
Last Updated: September 13, 2011
Condition(s): Obesity
7
Completed
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
Last Updated: September 13, 2011
Condition(s): Premature Ejaculation
8
Completed
A Safety and Tolerability Study of Administration of PSD502
Last Updated: September 13, 2011
Condition(s): Premature Ejaculation
9
Completed
A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis
Last Updated: September 13, 2011
Condition(s): Atopic Dermatitis
10
Completed
An Open-label Safety Study of S-888711
Last Updated: May 15, 2012
Condition(s): Immune Thrombocytopenia
11
Active, not recruiting
Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Last Updated: March 1, 2012
Condition(s): Attention Deficit Hyperactivity Disorder
12
Completed
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Last Updated: September 13, 2011
Condition(s): Obesity
13
Completed
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
Last Updated: September 13, 2011
Condition(s): Obesity
14
Completed
Study to Evaluate the Safety and Efficacy of S-297995 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain
Last Updated: September 13, 2011
Condition(s): Opioid Induced Bowel Dysfunction
15
Completed
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Last Updated: April 18, 2012
Condition(s): Atrophy; Vaginal Diseases
16
Terminated
A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Last Updated: September 13, 2011
Condition(s): Immune Thrombocytopenia (ITP)
17
Completed
Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus
Last Updated: September 13, 2011
Condition(s): Type 2 Diabetes Mellitus
18
Completed
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Last Updated: April 23, 2012
Condition(s): Atrophy; Vaginal Diseases
19
Active, not recruiting
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
Last Updated: April 18, 2012
Condition(s): Type 2 Diabetes Mellitus
20
Completed
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Last Updated: April 24, 2012
Condition(s): Atrophy; Vaginal Diseases

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Shionogi+Inc.

Page 1 of Clinical Trials for Shionogi Inc. [SPONSOR-COLLABORATORS], 26 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About